Targeting bladder disease where it matters

TARIS Biomedical® is a unique, therapeutically focused urology company developing powerful new treatments for millions of patients suffering from difficult-to-treat bladder diseases. TARIS is advancing therapies for debilitating conditions, including bladder cancer and overactive bladder, enabled by continuous local dosing where it is needed.

Year Invested: 2011
Location: Lexington, Mass.

Recent News

March 14, 2018
TARIS® Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy

March 14, 2018
TARIS® Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy

March 12, 2018
TARIS® to Present at Cowen Health Care Conference

Read More News

Associated Team Members

Cary Pfeffer, M.D.